BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33402473)

  • 1. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
    Thamrongwaranggoon U; Sangkhamanon S; Seubwai W; Saranaruk P; Cha'on U; Wongkham S
    In Vivo; 2021; 35(1):267-274. PubMed ID: 33402473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.
    Chusorn P; Namwat N; Loilome W; Techasen A; Pairojkul C; Khuntikeo N; Dechakhamphu A; Talabnin C; Chan-On W; Ong CK; Teh BT; Yongvanit P
    Tumour Biol; 2013 Jun; 34(3):1579-88. PubMed ID: 23417858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulin Expression in Hamsters during Opisthorchis viverrini Infection-Induced Cholangiocarcinogenesis.
    Upontain S; Sereerak P; Laha T; Sripa B; Tangkawatana P; Brindley PJ; Tangkawatana S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2437-2445. PubMed ID: 30255697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
    Boonmars T; Wu Z; Boonjaruspinyo S; Puapairoj A; Kaewsamut B; Nagano I; Pinlaor S; Yongvanit P; Wonkchalee O; Juasook A; Sudsarn P; Srisawangwong T
    Pathol Oncol Res; 2011 Jun; 17(2):219-27. PubMed ID: 20853076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans.
    Nair SS; Bommana A; Pakala SB; Ohshiro K; Lyon AJ; Suttiprapa S; Periago MV; Laha T; Hotez PJ; Bethony JM; Sripa B; Brindley PJ; Kumar R
    Hepatology; 2011 Oct; 54(4):1388-97. PubMed ID: 21725997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection.
    Mordvinov VA; Minkova GA; Kovner AV; Ponomarev DV; Lvova MN; Zaparina O; Romanenko SA; Shilov AG; Pakharukova MY
    Life Sci; 2021 Jul; 277():119494. PubMed ID: 33862109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
    Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
    World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Pugkhem A; Hahnvajanawong C; Chaiyagool J; Umezawa K; Okada S; Wongkham S
    PLoS One; 2014; 9(8):e106056. PubMed ID: 25170898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model.
    Loilome W; Yongvanit P; Wongkham C; Tepsiri N; Sripa B; Sithithaworn P; Hanai S; Miwa M
    Mol Carcinog; 2006 May; 45(5):279-87. PubMed ID: 16550611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Pinlaor S; Pairojkul C; Chamgramol Y; Takahashi Y
    Tumour Biol; 2012 Aug; 33(4):1169-78. PubMed ID: 22373585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini.
    Chaiyadet S; Tangkawattana S; Smout MJ; Ittiprasert W; Mann VH; Deenonpoe R; Arunsan P; Loukas A; Brindley PJ; Laha T
    PLoS Pathog; 2022 Sep; 18(9):e1010839. PubMed ID: 36137145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
    Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
    Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
    Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
    Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD
    Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.
    Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W
    Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.